| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3fbf1f584b6ced5b491d5d0288ef6c2d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y304-24035
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-6491
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-48 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-64 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48 |
| filingDate |
2014-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_169cc236ddc3b6dc85c04ee7539f673b |
| publicationDate |
2015-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015038058-A1 |
| titleOfInvention |
Modification of the mechanical properties of living tissue |
| abstract |
The invention is a method for manufacturing a medicament intended for the treatment and/or prevention of ischemia in Langerhans islets using a human matrix metalloproteinase (MMP), wherein the MMP is non-truncated. The invention also embraces a pharmaceutical composition as well as various methods applied to Langerhans islets. |
| priorityDate |
2013-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |